Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Provider Notice issued 12/02/2024

 

To: Enrolled Pharmacies
​Date December 2, 2024
​Re:
 Confirmation of Brand Name Coverage During Generic Drug Shortage per Public Act 103-0758

This notice confirms to pharmacies that the Department of Healthcare and Family Services (HFS) is in compliance with Public Act 103-0758 regarding generic drug shortages. 

It has been HFS’ policy that, if a generic drug or a therapeutic equivalent is unavailable due to a supply issue, as identified by either the Food and Drug Administration (FDA) or the American Society of Health-System Pharmacists (ASHP), and the dosage cannot be adjusted, the Department will cover a brand name eligible prescription drug until supply of the generic drug or therapeutic equivalent is available.

Questions regarding this notice may be directed to a pharmacy billing consultant in the Bureau of Professional and Ancillary Services at 877-782-5565.

 

Kelly Cunningham, Administrator
Division of Medical Programs